Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads

Journal of Infectious Diseases

Volumn 191, Issue 10, 2005, Pages 1670-1679

  Benveniste, Olivier ^a   Flahault, Antoine ^b   Rollot, Florence ^h   Elbim, Carole ^c   Estaquier, Jérôme ^d   Pédron, Béatrice ^f   Duval, Xavier ^e,g   Dereuddre Bosquet, Nathalie ⁱ   Clayette, Pascal ⁱ   Sterkers, Ghislaine ^f   Simon, Anne ^a   Ameisen, Jean Claude ^d   Leport, Catherine ^e,g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL TENON   (France)

^c Service d'Immunologie et d'Hématologie   (France)

^d INSERM   (France)

^e BICHAT HOSPITAL   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g Faculté Xavier Bichat   (France)

^h Service de Neurovirologie   (France)

ⁱ INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYTOKINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; VIRUS DNA;

ADULT; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL COUNT; CELL DEATH; CELL REGENERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; VIRUS LOAD;

EID: 20844459127     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/429670     Document Type: Article

References (37)

1. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
2. Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med 2000; 133:401-10.
3. Piketty C, Castiel P, Belec L, et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998; 12:745-50.
4. Mezzaroma I, Carlesimo M, Pinter E, et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 1999; 13:1187-93.
5. Fleury S, Pantaleo G. T cell regeneration in HIV-infected subjects under highly active antiretroviral therapy. Int J Mol Med 1999; 4:91-7.
6. Kolte L, Dreves AM, Ersboll AK, et al. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis 2002; 185:1578-85.
7. Mitsuyasu R. HIV protease inhibitors: immunological insights. AIDS 1999; 13(Suppl 1):S19-27.
8. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-5.
9. Ameisen JC. Programmed cell death and AIDS: from hypothesis to experiment. Immunol Today 1992; 13:388-91.
10. Ameisen JC. The origin of programmed cell death. Science 1996; 272:1278-9.
11. + T-cell death. J Virol 2002; 76:5966-73.
12. Pitrak DL, Bolanos J, Hershow R, Novak RM. Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis. AIDS 2001; 15:1317-9.
13. David D, Keller H, Nait-Ighil L, et al. Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy. AIDS 2002; 16:1093-101.
14. Clerici M, Sarin A, Berzofsky JA, et al. Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 1996; 10:603-11.
15. + T cells by macrophage-tropic HIV-1 and TGF-beta1. J Immunol 2001; 167:3360-6.
16. Estaquier J, Idziorek T, Zou W, et al. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182:1759-67.
17. Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immu-nodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996; 87:4959-66.
18. Ruiz-Mateos E, de la Rosa R, Franco JM, et al. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy. AIDS 2003; 17:947-54.
19. Carcelain G, Tubiana R, Samri A, et al. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol 2001; 75:234-41.
20. Douek DC, Vescio RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355:1875-81.
21. Benveniste O, Vaslin B, Le Grand R, et al. Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus. Proc Natl Acad Sci USA 1996; 93:3658-63.
22. Brazille P, Dereuddre-Bosquet N, Leport C, et al. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients. Clin Exp Immunol 2003; 131:304-11.
23. Teixeira L, Valdez H, McCune JM, et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001; 15:1749-56.
24. Benveniste O, Estaquier J, Lelievre JD, Vilde JL, Ameisen JC, Leport C. Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo. Eur J Clin Microbiol Infect Dis 2001; 20:896-7.
25. Marchetti G, Meroni L, Varchetta S, et al. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. J Infect Dis 2002; 186:606-16.
26. Lewin SR, Ribeiro RM, Kaufmann GR, et al. Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection. J Immunol 2002; 169:4657-66.
27. Chiappini E, Galli L, Azzari C, de Martino M. Interleukin-7 and immunologic failure despite treatment with highly active antiretroviral therapy in children perinatally infected with HIV-1. J Acquir Immune Defic Syndr 2003; 33:601-4.
28. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407:789-95.
29. Baumler CB, Bohler T, Herr I, Benner A, Krammer PH, Debatin KM. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996; 88:1741-6.
30. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181:2029-36.
31. Ameisen JC. From cell activation to cell depletion. The programmed cell death hypothesis of AIDS pathogenesis. Adv Exp Med Biol 1995; 374:139-63.
32. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002; 8:319-23.
33. Grossman Z, Herberman RB. T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host. Nat Med 1997; 3:486-90.
34. Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995; 154:5555-66.
35. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-40.
36. McCune JM. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 2001; 410:974-9.
37. Chun TW, Justement JS, Pandya P, et al. Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis 2002; 185:1672-6.